BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jácome AA, Coutinho AK, Lima EM, Andrade AC, Santos JSD. Personalized medicine in gastric cancer: Where are we and where are we going? World J Gastroenterol 2016; 22(3): 1160-1171 [PMID: 26811654 DOI: 10.3748/wjg.v22.i3.1160]
URL: https://www.wjgnet.com/1007-9327/full/v22/i3/1160.htm
Number Citing Articles
1
Kazuhiro Sakuta, Yu Sasaki, Yasuhiko Abe, Hidenori Sato, Masakuni Shoji, Takao Yaoita, Makoto Yagi, Naoko Mizumoto, Yusuke Onozato, Takashi Kon, Ayumi Koseki, Sonoko Sato, Ryoko Murakami, Yuki Miyano, Yoshiyuki Ueno. Somatic alterations and mutational burden are potential predictive factors for metachronous development of early gastric cancerScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-79195-0
2
Giulia Accordino, Sara Lettieri, Chandra Bortolotto, Silvia Benvenuti, Anna Gallotti, Elisabetta Gattoni, Francesco Agustoni, Emma Pozzi, Pietro Rinaldi, Cristiano Primiceri, Patrizia Morbini, Andrea Lancia, Giulia Maria Stella. From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers—A Multidisciplinary PerspectiveCancers 2020; 12(8): 2105 doi: 10.3390/cancers12082105
3
Qichao Hu, Zhibei Li, Yubing Li, Xinyu Deng, Yuan Chen, Xiao Ma, Jinhao Zeng, Yanling Zhao. Natural products targeting signaling pathways associated with regulated cell death in gastric cancer: Recent advances and perspectivesPhytotherapy Research 2023; 37(6): 2661 doi: 10.1002/ptr.7866
4
Jia-Xing Zhang, Yi Xu, Ying Gao, Cui Chen, Zhou-San Zheng, Miao Yun, Hui-Wen Weng, Dan Xie, Sheng Ye. RETRACTED ARTICLE: Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathwayMolecular Cancer 2017; 16(1) doi: 10.1186/s12943-017-0586-y
5
Matteo Micucci, Bian-Zhao Xiang, Chen-Min Ting, Hiu-Yee Kwan, Michele Mari, Michele Retini, Sabrina Burattini, Riham Osman, Udodinma Jude Okeke, Fuad Othman Abdullah, Federico Gianfanti, Michela Battistelli. Matching traditional Chinese medicine and western medicine-based research: Advanced nutraceutical development for proactive gastric cancer preventionWorld Journal of Gastrointestinal Oncology 2024; 16(9): 3798-3819 doi: 10.4251/wjgo.v16.i9.3798
6
Ke Ning, Yangguang Shao, Yuxin He, Fei Wang, Xi Cui, Furong Liu, Danni Li, Feng Li. Histone demethylase Jumonji domain‐containing 1A inhibits proliferation and progression of gastric cancer by upregulating runt‐related transcription factor 3Cancer Science 2020; 111(10): 3679 doi: 10.1111/cas.14594
7
Simona Laurino, Pellegrino Mazzone, Vitalba Ruggieri, Pietro Zoppoli, Giovanni Calice, Antonella Lapenta, Mario Ciuffi, Orazio Ignomirelli, Giulia Vita, Alessandro Sgambato, Sabino Russi, Geppino Falco. Cationic Channel TRPV2 Overexpression Promotes Resistance to Cisplatin-Induced Apoptosis in Gastric Cancer CellsFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.746628
8
Raquel Carvalho Montenegro, Alison Howarth, Alessandro Ceroni, Vita Fedele, Batoul Farran, Felipe Pantoja Mesquita, Martin Frejno, Benedict-Tilman Berger, Stephanie Heinzlmeir, Heba Z. Sailem, Roberta Tesch, Daniel Ebner, Stefan Knapp, Rommel Burbano, Bernhard Kuster, Susanne Müller. Identification of molecular targets for the targeted treatment of gastric cancer using dasatinibOncotarget 2020; 11(5): 535 doi: 10.18632/oncotarget.27462
9
Weilin Li, Chi Chun Wong, Xiaoming Zhang, Wei Kang, Geicho Nakatsu, Qinfu Zhao, Huarong Chen, Minnie Yin Yin Go, Philip Wai Yan Chiu, Xiaohong Wang, Jiafu Ji, Xiaona Li, Zongwei Cai, Enders Kwok Wai Ng, Jun Yu. CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1α axis to inhibit gastric tumorigenesisOncogene 2018; 37(50): 6383 doi: 10.1038/s41388-018-0402-1
10
Bo-Kyung Kim, Jae-Ho Cheong, Joo-Young Im, Hyun Seung Ban, Seon-Kyu Kim, Mi-Jung Kang, Jungwoon Lee, Seon-Young Kim, Kyung-Chan Park, Soonmyung Paik, Misun Won. PI3K/AKT/β-Catenin Signaling Regulates Vestigial-Like 1 Which Predicts Poor Prognosis and Enhances Malignant Phenotype in Gastric CancerCancers 2019; 11(12): 1923 doi: 10.3390/cancers11121923
11
Paulina Stokłosa, Anna Borgström, Sven Kappel, Christine Peinelt. TRP Channels in Digestive Tract CancersInternational Journal of Molecular Sciences 2020; 21(5): 1877 doi: 10.3390/ijms21051877
12
Joschka Haltaufderheide, Sebastian Wäscher, Bernhard Bertlich, Jochen Vollmann, Anke Reinacher-Schick, Jan Schildmann. “I need to know what makes somebody tick …”: Challenges and Strategies of Implementing Shared Decision-Making in Individualized OncologyThe Oncologist 2019; 24(4): 555 doi: 10.1634/theoncologist.2017-0615
13
Qiang Li, Yugang Ge, Xiaofeng Chen, Lu Wang, Yiwen Xia, Zhipeng Xu, Zheng Li, Weizhi Wang, Li Yang, Diancai Zhang, Zekuan Xu. LEM domain containing 1 promotes proliferation via activating the PI3K/Akt signaling pathway in gastric cancerJournal of Cellular Biochemistry 2019; 120(9): 15190 doi: 10.1002/jcb.28783
14
Liqiang Zhou, Shi H. Li, You Wu, Lin Xin. Establishment of a prognostic model of four genes in gastric cancer based on multiple data setsCancer Medicine 2021; 10(10): 3309 doi: 10.1002/cam4.3654
15
Yaoyao He, Miao Yang, Rong Hou, Shuangquan Ai, Tingting Nie, Jun Chen, Huaifei Hu, Xiaofang Guo, Yulin Liu, Zilong Yuan. Preoperative prediction of perineural invasion and lymphovascular invasion with CT radiomics in gastric cancerEuropean Journal of Radiology Open 2024; 12: 100550 doi: 10.1016/j.ejro.2024.100550
16
Angela Buonadonna, Gian Maria Miolo, Valentina Fanotto, Federico Navarria, Elisa Palazzari, Claudio Belluco, Stefania Maiero, Vincenzo Canzonieri, Giulio Bertola, Antonino De Paoli. Gastric Cancer In The Precision Medicine EraCurrent Clinical Pathology 2019; : 121 doi: 10.1007/978-3-030-04861-7_7
17
Felipe Pantoja Mesquita, Pedro Filho Noronha Souza, Emerson Lucena da Silva, Luina Benevides Lima, Lais Lacerda Brasil de Oliveira, Caroline Aquino Moreira-Nunes, William J. Zuercher, Rommel Mario Rodríguez Burbano, Maria Elisabete Amaral de Moraes, Raquel Carvalho Montenegro. Kinase Inhibitor Screening Displayed ALK as a Possible Therapeutic Biomarker for Gastric CancerPharmaceutics 2022; 14(9): 1841 doi: 10.3390/pharmaceutics14091841
18
Philippe Taniere, Brendan O’Sullivan, Matthew Evans, Frances Hughes. Bancroft's Theory and Practice of Histological Techniques2019; : 395 doi: 10.1016/B978-0-7020-6864-5.00020-7
19
Zhicheng Chen, Guangfeng Zhang, Yi Liu, Kexin Zhu. Radiomics analysis in predicting vascular invasion in gastric cancer based on enhanced CT: a preliminary studyBMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12793-7
20
Hosein Kouchaki, Parnia Kamyab, Farzaneh Darbeheshti, Arezou Gharezade, Hamed Fouladseresht, Reza Tabrizi. miR-939, as an important regulator in various cancers pathogenesis, has diagnostic, prognostic, and therapeutic values: a reviewJournal of the Egyptian National Cancer Institute 2024; 36(1) doi: 10.1186/s43046-024-00220-8
21
Zitong Wang, Yingying Chen, Xiaoyu Li, Yuhan Zhang, Xiaokun Zhao, Hao Zhou, Xuebo Lu, Lili Zhao, Qiang Yuan, Yunshu Shi, Jimin Zhao, Ziming Dong, Yanan Jiang, Kangdong Liu. Tegaserod Maleate Suppresses the Growth of Gastric Cancer In Vivo and In Vitro by Targeting MEK1/2Cancers 2022; 14(15): 3592 doi: 10.3390/cancers14153592
22
Yi Yang, Yi Nan, Yu-Hua Du, Shi-Cong Huang, Dou-Dou Lu, Jun-Fei Zhang, Xia Li, Yan Chen, Lei Zhang, Ling Yuan. 18β-glycyrrhetinic acid promotes gastric cancer cell autophagy and inhibits proliferation by regulating miR-328-3p/signal transducer and activator of transcription 3World Journal of Gastroenterology 2023; 29(27): 4317-4333 doi: 10.3748/wjg.v29.i27.4317
23
Wenji Xu, Yaping Zhang, Yingrui Su, Libin Li, Xinxia Yang, Lixing Wang, Hongzhi Gao. USP9X regulates the proliferation, survival, migration and invasion of gastric cancer cells by stabilizing MTH1BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03321-9
24
Wenjuan Zhou, Liying Ma, Jing Yang, Hui Qiao, Lingyu Li, Qian Guo, Jinlian Ma, Lijuan Zhao, Junwei Wang, Guozhong Jiang, Xiangbin Wan, Mariusz Adam Goscinski, Lina Ding, Yichao Zheng, Wencai Li, Hongmin Liu, Zhenhe Suo, Wen Zhao. Potent and specific MTH1 inhibitors targeting gastric cancerCell Death & Disease 2019; 10(6) doi: 10.1038/s41419-019-1665-3
25
Yalan Dai, Liqiong Yang, Abass Sakandar, Duoli Zhang, Fukuan Du, Xinyi Zhang, Linglin Zou, Yueshui Zhao, Jigang Wang, Zhenhua Zhang, Xu Wu, Mingxing Li, Xiao Ling, Lei Yu, Lishu Dong, Jing Shen, Zhangang Xiao, Qinglian Wen. Vemurafenib inhibits immune escape biomarker BCL2A1 by targeting PI3K/AKT signaling pathway to suppress breast cancerFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.906197
26
Jiansong Ji, Weiqian Chen, Weishuai Lian, Ruijie Chen, Jinqing Yang, Qianqian Zhang, Qiaoyou Weng, Zia Khan, Jie Hu, Xi Chen, Peng Zou, Xiaoming Chen, Guang Liang. (S)-crizotinib reduces gastric cancer growth through oxidative DNA damage and triggers pro-survival akt signalCell Death & Disease 2018; 9(6) doi: 10.1038/s41419-018-0667-x
27
Batoul Farran, Susanne Müller, Raquel C Montenegro. Gastric cancer management: Kinases as a target therapyClinical and Experimental Pharmacology and Physiology 2017; 44(6): 613 doi: 10.1111/1440-1681.12743
28
Xiaofeng Chen, Zhiqi Yang, Jiada Yang, Yuting Liao, Peipei Pang, Weixiong Fan, Xiangguang Chen. Radiomics analysis of contrast-enhanced CT predicts lymphovascular invasion and disease outcome in gastric cancer: a preliminary studyCancer Imaging 2020; 20(1) doi: 10.1186/s40644-020-00302-5
29
Omar Abdel-Rahman. Validation of the 8th AJCC staging system for gastric cancer in a population-based settingExpert Review of Gastroenterology & Hepatology 2018; 12(5): 525 doi: 10.1080/17474124.2018.1413348
30
Nicola Fusco, Silvano Bosari. <i>HER2</i> aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologistsWorld Journal of Gastroenterology 2016; 22(35): 7926-7937 doi: 10.3748/wjg.v22.i35.7926
31
Chen Xu, Yalan Liu, Dongxian Jiang, Qian Li, Xiaowen Ge, Ying Zhang, Jie Huang, Jieakesu Su, Yuan Ji, Jun Hou, Shaohua Lu, Yingyong Hou, Tianshu Liu. Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal typeOncotarget 2017; 8(20): 33185 doi: 10.18632/oncotarget.16567
32
Junyong Weng, Jingbo Xiao, Yushuai Mi, Xu Fang, Yahuang Sun, Shanbao Li, Zhiwei Qin, Xu Li, Tingting Liu, Senlin Zhao, Lisheng Zhou, Yugang Wen. PCDHGA9 acts as a tumor suppressor to induce tumor cell apoptosis and autophagy and inhibit the EMT process in human gastric cancerCell Death & Disease 2018; 9(2) doi: 10.1038/s41419-017-0189-y
33
Dan Zhang, Jiewen Zheng, Mengwei Ni, Jiarui Wu, Kuaihuan Wang, Xiaojiao Duan, Xiaomeng Zhang, Bing Zhang. Comparative efficacy and safety of Chinese herbal injections combined with the FOLFOX regimen for treating gastric cancer in China: a network meta-analysisOncotarget 2017; 8(40): 68873 doi: 10.18632/oncotarget.20320
34
Michelle D. Hackshaw, Christine L. Bui, Amy Ladner, Nora Tu, Zahidul Islam, Mary E. Ritchey, Maribel Salas. Review of survival, safety, and clinical outcomes in HER2+ metastatic gastric cancer following the administration of trastuzumabPost-Trastuzumab Gastric CancerCancer Treatment and Research Communications 2020; 24: 100189 doi: 10.1016/j.ctarc.2020.100189
35
Masashi Fukushima, Hirokazu Fukui, Jiro Watari, Chiyomi Ito, Ken Hara, Hirotsugu Eda, Toshihiko Tomita, Tadayuki Oshima, Hiroto Miwa. Gastric Xanthelasma, Microsatellite Instability and Methylation of Tumor Suppressor Genes in the Gastric Mucosa: Correlation and Comparison as a Predictive Marker for the Development of Synchronous/Metachronous Gastric CancerJournal of Clinical Medicine 2021; 11(1): 9 doi: 10.3390/jcm11010009
36
Sebahattin Celik, Remzi Kızıltan, Eyüp M Yılmaz, Özkan Yılmaz, Halit Demir. Potential Diagnostic and Prognostic Significance of Plasma Prolidase Activity in Gastric CancerBiomarkers in Medicine 2017; 11(4): 319 doi: 10.2217/bmm-2016-0367
37
Bryson W. Katona, Anil K. Rustgi. Gastric Cancer Genomics: Advances and Future DirectionsCellular and Molecular Gastroenterology and Hepatology 2017; 3(2): 211 doi: 10.1016/j.jcmgh.2017.01.003